Fact CheckerSign in

NCT05188027Recruiting

Aerobic vs Resistance Exercise in Post-menopausal Women With Type 1 Diabetes

Acute Glycemic Effects of Aerobic and Resistance Exercise in Post-menopausal Women With Type 1 Diabetes

Source: ClinicalTrials.gov · Last updated 16 Mar 2026

Brief summary (registry, in English)

Participants will be asked to wear a continuous glucose monitor for at least three days on three separate occasions. One testing session will be a no-exercise resting control session (90 minutes). One will be a moderate aerobic exercise session (30 minutes of exercise, 60 minutes of recovery), and the third will be a moderate weight-lifting session (\~30 minutes of exercise, 60 minutes of recovery).The investigators will measure changes in blood glucose during exercise by drawing blood during and after exercise. Post-exercise glucose trends will be examined using continuous glucose monitoring.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
20 (estimated)
First submitted
8 Dec 2021
Start date
16 Nov 2021
Primary completion date
30 Mar 2027
Lead sponsor
University of Alberta
NCT number
NCT05188027

What you commit to

  • Study type: Interventional
  • Planned participants: 20
  • From 16 Nov 2021 to the primary completion date, 30 Mar 2027
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • history of cardiovascular disease

Lab values

  • HbA1c \> 9.9 %
  • use of medications (other than insulin) that affect glucose metabolism

Other

  • frequent and unpredictable hypoglycemia
  • change in insulin management strategy within the last 2 months
  • blood pressure \> 140 / 95
  • severe peripheral neuropathy
  • musculoskeletal injuries interfering with exercise performance
  • BMI \> 30 kg/m2
  • smoking
  • moderate to high alcohol intake (\> 2 drinks/day)

Who the study is looking for

  • type 1 diabetes, diagnosed for at least one year
  • post-menopause (at least one year since last menstrual period), or have had a hysterectomy and bilateral salpingo oophorectomy
  • able to perform aerobic and resistance exercise
  • able to visit the lab in Edmonton, Alberta (University of Alberta)

Age in the registry: 45 years to 75 years · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Alberta Diabetes Institute
Coordinator of this site? Confirm its status
EdmontonCanadaRecruiting
Institut de Recherches Cliniques de Montreal
Coordinator of this site? Confirm its status
MontrealCanadaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.